News
Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Basilard BioTech, a Southern California biotechnology company pioneering novel ...
This research investigates how to optimize mRNA transfection in human T-cells utilizing the jetMESSENGER ® transfection reagent. By using advanced bioanalytical instruments like the Incucyte ® ...
Transfection is a crucial non-viral technique for introducing DNA or RNA into cells, yet achieving high efficiency and consistency can be challenging, particularly with difficult cell types.
GlobalData on MSN
Kytopen and BlueWhale Bio partner for cell therapy innovation
The partnership aims to create a non-viral system to expedite engineered cell therapy delivery by addressing bottlenecks.
News-Medical.Net on MSN
Streamlining CAR T cell production through in vivo therapeutic strategies
This review article highlights the transformative potential of in vivo CAR T cell therapy in addressing the limitations of ...
In the rapidly evolving field of lipid nanoparticle (LNP) research, the integration of advanced technologies is crucial for ...
This application note explores how advanced SFM formulations can dramatically improve CRISPR-modified CAR-T cell production ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results